(HealthDay)—Medications used for enlarged prostate are associated with a small, but significant, increase in developing heart failure, according to a study published online Feb. 22 in The Journal of Urology.
AI Screening for Heart Failure Clinical Trial Speeds up Enrollment, Study Finds11 hours ago FDA Clears GlutenID Test for Easier Celiac Screening12 hours ago OPN-6602 Granted Orphan Drug Designation in R/R Multiple Myeloma2 days ago Last Week's Top Feed FDA Approves Insulin-aspart-szjj as Bios...
Starting indicated heart failure meds in-hospital: Progress, opportunitiesStiles, SteveCardiology News
A New Era of control in hypertension, type 2 diabetes, cholesterol, and heart failureis here. MedsEngine is a clinical decision support software solution that delivers real-time, personalized medication recommendations. It uses state-of-the-art cloud technology and integrates with electronic health ...
Generic Lasix is used for treating high blood pressure or water retention (swelling) associated with congestive heart failure, liver disease or kidney disease. $ 0.61 Buy now! Revatio Sildenafil 20mg Generic Revation relaxes muscles and increases blood flow to particular areas of the body. ...
, in 6.6 years of follow-up, compared with patients who filled their prescriptions less than a quarter of the time (very low adherence), those who filled their prescriptions more than three-quarters of the time (high adherence) had a 34% lower risk of being hospitalized for heart failure....
HalesMeds helps over 100,000 health care professionals worldwide with evidence-based information on medication safety for breastfeeding mothers. Now including new drugs for weight loss like Ozempic and Wegovy, heart failure drugs such as Entresto, medications for anxiety, postpartum depression, and ov...
SUGGESTED for you Focus on getting your patient's heart rate lower than 70 while maintaining their blood pressure, she said. "Another question we have is, When these patients come into hospitals, what should we do with the beta blocker? Should we continue it? Should we stop it? If you ...
The fats collect in blood vessels and tissues, raising the risk of heart attack, stroke and kidney failure. The FDA green light came four days after Europe granted a marketing license to the treatment. Elfabrio was fast-tracked for approval by the FDA in 2018 but pandemic-relat...
the SHIFT paper [2], which points out shortfalls in the background medical therapy of SHIFT participants, at least according to contemporary standards, questions how far the study's results can be generalized and s...